These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19701734)

  • 41. [Calcium pros and cons: long term use of bisphosphonates. Bisphosphonates should be used for postmenopausal osteoporosis for a long term].
    Soen S
    Clin Calcium; 2011 Oct; 21(10):1543-6. PubMed ID: 21960242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Osteoporosis: a clinical perspective].
    Matikainen N
    Duodecim; 2016; 132(11):1051-8. PubMed ID: 27400591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Differential therapy of osteoporosis--an overview based on recent findings regarding the pathogenesis].
    Schacht E
    Z Rheumatol; 1994; 53(5):274-98. PubMed ID: 7810237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advances in the medical management of osteoporosis.
    Kates SL; Kates OS; Mendelson DA
    Injury; 2007 Sep; 38 Suppl 3():S17-23. PubMed ID: 17723788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.
    CMAJ; 1996 Oct; 155(8):1113-33. PubMed ID: 8873639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comprehensive Interventions Including Vitamin D Effectively Reduce the Risk of Falls in Elderly Osteoporotic Patients.
    Feng F; Shi G; Chen H; Jia P; Bao L; Xu F; Sun QC; Tang H
    Orthop Surg; 2021 Jun; 13(4):1262-1268. PubMed ID: 33951328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A rationale for vitamin D prescribing in a falls clinic population.
    Sahota O
    Age Ageing; 2003 Nov; 32(6):681; author reply 681-2. PubMed ID: 14600015
    [No Abstract]   [Full Text] [Related]  

  • 48. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
    McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Osteoporosis therapy. A pluralistic approach].
    Lehmann R; Allolio B
    Internist (Berl); 1998 Dec; 39(12):1253-63. PubMed ID: 10198832
    [No Abstract]   [Full Text] [Related]  

  • 50. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.
    Hodgson SF; Watts NB; Bilezikian JP; Clarke BL; Gray TK; Harris DW; Johnston CC; Kleerekoper M; Lindsay R; Luckey MM; McClung MR; Nankin HR; Petak SM; Recker RR;
    Endocr Pract; 2003; 9(6):544-64. PubMed ID: 14715483
    [No Abstract]   [Full Text] [Related]  

  • 51. Pharmacologic management of osteoporosis.
    Aynardi M; Ilyas AM
    J Hand Surg Am; 2013 Mar; 38(3):588-92. PubMed ID: 23312206
    [No Abstract]   [Full Text] [Related]  

  • 52. Update on Osteoporosis Screening and Management.
    Anam AK; Insogna K
    Med Clin North Am; 2021 Nov; 105(6):1117-1134. PubMed ID: 34688418
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.
    Kanis JA; Delmas P; Burckhardt P; Cooper C; Torgerson D
    Osteoporos Int; 1997; 7(4):390-406. PubMed ID: 9373575
    [No Abstract]   [Full Text] [Related]  

  • 54. [Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009].
    Dimai HP; Pietschmann P; Resch H; Preisinger E; Fahrleitner-Pammer A; Dobnig H; Klaushofer K;
    Wien Med Wochenschr Suppl; 2009; (122):1-34. PubMed ID: 19484202
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An overview of osteoporosis.
    Shepherd AJ
    Altern Ther Health Med; 2004; 10(2):26-33; quiz 34, 92. PubMed ID: 15055091
    [No Abstract]   [Full Text] [Related]  

  • 56. Diagnosis and treatment of osteoporosis.
    Sweet MG; Sweet JM; Jeremiah MP; Galazka SS
    Am Fam Physician; 2009 Feb; 79(3):193-200. PubMed ID: 19202966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The hip fracture threat.
    Morris HA; Need AG; Nordin BE
    Med J Aust; 1999 May; 170(10):459-60. PubMed ID: 10376016
    [No Abstract]   [Full Text] [Related]  

  • 58. [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?].
    MMW Fortschr Med; 2004 May; 146(21):63. PubMed ID: 15373093
    [No Abstract]   [Full Text] [Related]  

  • 59. Osteoporotic fractures: background and prevention strategies.
    Wark JD
    Maturitas; 1996 Mar; 23(2):193-207. PubMed ID: 8735357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An approach to postmenopausal osteoporosis treatment: a case study review.
    Kessenich C
    J Am Acad Nurse Pract; 2003 Dec; 15(12):539-45. PubMed ID: 14983569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.